Facilities & Resources

New Multiple Sclerosis Drug, Backed by 40 Years of Research, Could Halt Disease

A newly approved drug that is the first to reflect the current scientific understanding of multiple sclerosis is holding new hope for the hundreds of thousands Americans living with the disease. It also highlights the importance of clinician scientists like UCSF’s Stephen Hauser who are working to transform research into cures for patients.

Pages